Emotional visual mismatch negativity: a joint investigation of social and non-social dimensions in adults with autism.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
05 01 2021
Historique:
received: 21 07 2020
accepted: 03 12 2020
revised: 27 11 2020
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 22 6 2021
Statut: epublish

Résumé

Unusual behaviors and brain activity to socio-emotional stimuli have been reported in Autism Spectrum Disorder (ASD). Atypical reactivity to change and intolerance of uncertainty are also present, but little is known on their possible impact on facial expression processing in autism. The visual mismatch negativity (vMMN) is an electrophysiological response automatically elicited by changing events such as deviant emotional faces presented among regular neutral faces. While vMMN has been found altered in ASD in response to low-level changes in simple stimuli, no study has investigated this response to visual social stimuli. Here two deviant expressions were presented, neutral and angry, embedded in a sequence of repetitive neutral stimuli. vMMN peak analyses were performed for latency and amplitude in early and late time windows. The ASD group presented smaller amplitude of the late vMMN to both neutral and emotional deviants compared to the typically developed adults (TD) group, and only the TD group presented a sustained activity related to emotional change (i.e., angry deviant). Source reconstruction of the vMMNs further revealed that any change processing elicited a reduced activity in ASD group compared to TD in the saliency network, while the specific processing emotional change elicited activity in the temporal region and in the insula. This study confirms atypical change processing in ASD and points to a specific difficulty in the processing of emotional changes, potentially playing a crucial role in social interaction deficits. Nevertheless, these results require to be further replicated with a greater sample size and generalized to other emotional expressions.

Identifiants

pubmed: 33414385
doi: 10.1038/s41398-020-01133-5
pii: 10.1038/s41398-020-01133-5
pmc: PMC7791028
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10

Subventions

Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : ANR-12-JSH2 0001-01-AUTATTEN
Pays : International

Références

Trends Cogn Sci. 2012 Oct;16(10):504-10
pubmed: 22959875
Front Hum Neurosci. 2012 Dec 19;6:334
pubmed: 23267324
J Exp Child Psychol. 2011 Aug;109(4):430-44
pubmed: 21458825
J Autism Dev Disord. 2019 Mar;49(3):871-886
pubmed: 30374763
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Aug;3(8):657-666
pubmed: 30092916
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:412-426
pubmed: 30381235
Neuroreport. 2011 Oct 5;22(14):669-73
pubmed: 21878790
J Autism Dev Disord. 2011 Jun;41(6):705-14
pubmed: 20827502
J Autism Dev Disord. 2002 Aug;32(4):249-61
pubmed: 12199131
Behav Brain Funct. 2009 Jul 20;5:30
pubmed: 19619272
Comput Intell Neurosci. 2011;2011:158970
pubmed: 21687568
Front Neurosci. 2017 May 31;11:314
pubmed: 28620278
Brain Cogn. 2019 Nov;136:103599
pubmed: 31536931
Appl Psychophysiol Biofeedback. 2009 Mar;34(1):37-51
pubmed: 19199028
J Neurodev Disord. 2018 Sep 18;10(1):28
pubmed: 30227832
Neuroimage. 2006 Jan 15;29(2):475-84
pubmed: 16115783
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
Neuroreport. 2013 Mar 27;24(5):207-11
pubmed: 23399996
Front Hum Neurosci. 2013 Sep 11;7:557
pubmed: 24062661
J Vis. 2014 Sep 05;14(11):
pubmed: 25194015
Psychophysiology. 2013 Mar;50(3):240-52
pubmed: 23316882
J Cogn Neurosci. 2019 Nov;31(11):1631-1640
pubmed: 31274394
Front Hum Neurosci. 2017 Jan 30;11:18
pubmed: 28194102
Neuropsychol Rev. 2010 Sep;20(3):290-322
pubmed: 20809200
Psychophysiology. 1991 Mar;28(2):240-4
pubmed: 1946890
Cereb Cortex. 2012 Aug;22(8):1774-85
pubmed: 21945904
Nat Neurosci. 2000 Mar;3(3):292-7
pubmed: 10700263
Neuroimage. 2013 Jul 15;75:117-122
pubmed: 23501051
J Am Acad Child Adolesc Psychiatry. 2008 Apr;47(4):443-454
pubmed: 18356706
J Autism Dev Disord. 2015 Jun;45(6):1774-84
pubmed: 25563453
Behav Brain Funct. 2012 Feb 02;8:7
pubmed: 22300600
Psychophysiology. 2009 Mar;46(2):402-9
pubmed: 19207207
Int J Psychophysiol. 2019 Dec;146:190-200
pubmed: 31669316
J Autism Dev Disord. 2006 Jan;36(1):27-43
pubmed: 16453071
J Autism Dev Disord. 2016 Oct;46(10):3377-86
pubmed: 27475419
Soc Cogn Affect Neurosci. 2009 Sep;4(3):215-26
pubmed: 19574440
Neurosci Biobehav Rev. 2017 Sep;80:488-515
pubmed: 28698082
Int J Psychophysiol. 2012 Feb;83(2):240-7
pubmed: 21968196
Neuroreport. 1996 Nov 25;7(18):3005-8
pubmed: 9116228
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Electroencephalogr Clin Neurophysiol. 1994 May;92(3):225-37
pubmed: 7514992
Brain. 2000 Nov;123 ( Pt 11):2203-12
pubmed: 11050021
PLoS One. 2013 Oct 07;8(10):e75444
pubmed: 24116046
Cortex. 2016 Jul;80:76-112
pubmed: 27174389
Psychophysiology. 2002 Sep;39(5):577-84
pubmed: 12236323
Int J Psychophysiol. 2014 Sep;93(3):311-5
pubmed: 24933413
Clin Neurophysiol. 2002 May;113(5):702-12
pubmed: 11976050
Neurosci Lett. 2010 Mar 12;472(1):33-7
pubmed: 20117175
Front Hum Neurosci. 2013 Mar 06;7:62
pubmed: 23507615
Neuroimage. 2004 Jul;22(3):1141-50
pubmed: 15219586
Psychophysiology. 2001 Jul;38(4):723-7
pubmed: 11446587
Biol Psychiatry. 2009 Jan 1;65(1):63-74
pubmed: 18996505
Neuroimage Clin. 2013 Feb 07;2:303-12
pubmed: 24179785
PLoS One. 2014 Mar 14;9(3):e90993
pubmed: 24632708
Hum Brain Mapp. 2015 Sep;36(9):3641-52
pubmed: 26047176
Soc Neurosci. 2011;6(1):22-30
pubmed: 20446172
Front Hum Neurosci. 2018 May 04;12:186
pubmed: 29780315

Auteurs

Klara Kovarski (K)

UMR 1253 iBrain, Université de Tours, Inserm, Tours, France. Klara.kovarski@u-paris.fr.
Hôpital Fondation Adolphe de Rothschild, Paris, France. Klara.kovarski@u-paris.fr.
Université de Paris, CNRS, Integrative Neuroscience and Cognition Center, 75006, Paris, France. Klara.kovarski@u-paris.fr.

Judith Charpentier (J)

UMR 1253 iBrain, Université de Tours, Inserm, Tours, France.

Sylvie Roux (S)

UMR 1253 iBrain, Université de Tours, Inserm, Tours, France.

Magali Batty (M)

Université de Toulouse, CERPPS, Toulouse, France.

Emmanuelle Houy-Durand (E)

UMR 1253 iBrain, Université de Tours, Inserm, Tours, France.
CHRU de Tours, Centre Universitaire de Pédopsychiatrie, Tours, France.

Marie Gomot (M)

UMR 1253 iBrain, Université de Tours, Inserm, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH